Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The injectable hormone was approved to treat excess abdominal fat in those with antiretroviral-associated lipodystrophy.
A new study on harmful algal blooms suggests they may be more harmful to people than previously known.
Rising rates of obesity are fueling the epidemic.
Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Researchers have identified biomarkers that can identify NAFLD and rule out advanced fibrosis.
Study finds people who took daily aspirin had a lower risk of NASH and advanced liver scarring.
A look at 3 forms of fatty liver disease: Non-Alcoholic Fatty Liver, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis
Researchers argue that the distinctions between the two conditions are quite blurred.
Advocates at the Global Liver Institute are declaring the liver disease a “hidden epidemic” across the globe.
In a study of pregnant women, intrahepatic cholestasis, which causes severe itching, was more common in those with fatty liver disease.
The popular weed killer has been the subject of several lawsuits over its potential health effects.
If you live with liver disease, you need knowledge about how your liver works, so you can give it lots of support, and live longer...
The herbicide has been making headlines over allegations it could be linked to cancer—but scientists say there are other risks too.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.